Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma

Melanoma Research

Volumn 18, Issue 5, 2008, Pages 330-335

  Gu, Fangyi ^a   Qureshi, Abrar A ^b,c   Niu, Tianhua ^a   Kraft, Peter ^a   Guo, Qun ^a,b   Hunter, David J ^a,b   Han, Jiali ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHANNING LABORATORY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Interleukin receptors; Interleukins; Melanoma; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MELANOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKINS; INTRONS; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; SKIN NEOPLASMS;

EID: 53549134937     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32830658b2     Document Type: Article

References (32)

1. American Cancer Society. Cancer facts & figures 2007. Atlanta: American Cancer Society; 2007.
2. Penn I. Depressed immunity and skin cancer. Immunol Today 1984; 5: 291-293.
3. Yue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, Manolio S, et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-1, HLA class-11, and ICAM-1 molecules. Int J Cancer 1997; 71:630-637.
4. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-360.
5. Chen Q, Daniel V, Maher DW, Hersey P. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 1994; 56:755-760.
6. Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res 1999; 19:697-703.
7. Shreedhar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 1998; 160:3783-3789.
8. Lu C, Vickers MF, Kerbel RS. Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 992; 89: 9215-9219.
9. Howell WM, Turner SJ, Bateman AC, Theaker JM. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun 2001; 2:25-31.
10. Howell WM, Turner SJ, Theaker JM, Bateman AC. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 2003; 30:409-414.
11. Nikolova PN, Pawelec GP, Mihailova SM, Ivanova Ml, Myhailova AP, Baltadjieva DN, et al.. Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol Immunother 2007;56:371-379.
12. Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol 2006; 35:1514-1521.
13. Qi L, van Dam RM, Meigs JB, Manson JE, Hunter D, Hu FB. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 2006; 15:1914-1920.
14. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Wat Genet 2005; 37:1217-1223.
15. Landi S, Bottari F, Gemignani F, Gioia-Patricola L, Guino E, Osorio A, et al.. Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Eur J Cancer 2007; 43:762-768.
16. Brown EE, Fallin MD, Goedert JJ, Hutchinson A, Vitale F, Lauria C, et al.. Host immunogenetics and control of human herpesvirus-8 infection. J Infect Dis 2006; 193:1054-1062.
17. Howell WM, Rose-Zerilli MJ. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr 2007; 137 (1 Suppl):194S-199S.
18. Han J, Colditz GA, Liu JS, Hunter DJ. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:1539-1544.
19. Henikoff S, Henikoff JG. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A 1992; 89:10915-10919.
20. Sunyaev S, Ramensky V, Koch I, Lathe W III, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001; 10: 591-597.
21. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003; 31:3812-3814.
22. Yue P, Melamud E, Moult J. SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformat 2006; 7:166.
23. Wang L, Liu S, Niu T, Xu X. SNPHunter: a bioinformatic software for single nucleotide polymorphism data acquisition and management. BMC Bioinformat 2005; 6:60.
24. Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol 1997; 4:311-323.
25. Takai D, Jones PA. The CpG island searcher: a new WWW resource. In Silico Biol 2003; 3:235-240.
26. Martinez-Escribano JA, Moya-Quiles MR, Muro M, Montes-Ares O, Hernandez-Caselles T, Frias JF, et al. Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients. Melanoma Res 2002; 12:465-469.
27. Soubrane C, Rixe O, Meric JB, Khayat D, Mouawad R. Pretreatment serum interleukin-6 concentration as a prognostic factor of overall survival in metastatic malignant melanoma patients treated with biochemotherapy: a retrospective study. Melanoma Res 2005; 15:199-204.
28. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al.. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
29. Mullberg J, Oberthur W, Lottspeich F, Mehl E, Dittrich E, Graeve L, et al. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol 1994; 152:4958-4968.
30. Galicia JC, Tai H, Komatsu Y, Shimada Y, Akazawa K, Yoshie H. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun 2004; 5:513-516.
31. Alonso R, Suarez A, Castro P, Lacave AJ, Gutierrez C. Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease. Melanoma Res 2005; 15:53-60.
32. Vuoristo MS. The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma. Cancer Genet Cytogenet 2007; 176:54-57.